Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura
This study has been completed.
Study NCT00162006.
Last updated on October 18, 2006.
Information provided by Baxter Healthcare Corporation
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
